Brakenhoff RH - Search Results

1

Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Pantel K, Brakenhoff RH, Brandt B. Pantel K, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2008 May;8(5):329-40. doi: 10.1038/nrc2375. Nat Rev Cancer. 2008. PMID: 18404148 Review.

2

Dissecting the metastatic cascade.

Pantel K, Brakenhoff RH. Pantel K, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2004 Jun;4(6):448-56. doi: 10.1038/nrc1370. Nat Rev Cancer. 2004. PMID: 15170447 Review. No abstract available.

3

Molecular signature associated with bone marrow micrometastasis in human breast cancer.

Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K. Woelfle U, et al. Cancer Res. 2003 Sep 15;63(18):5679-84. Cancer Res. 2003. PMID: 14522883

4

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.

Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmén J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H. Wrage M, et al. Among authors: brakenhoff rh. Clin Cancer Res. 2009 Mar 1;15(5):1566-74. doi: 10.1158/1078-0432.CCR-08-2188. Epub 2009 Feb 10. Clin Cancer Res. 2009. PMID: 19208797

5

Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer.

Woelfle U, Sauter G, Santjer S, Brakenhoff R, Pantel K. Woelfle U, et al. Clin Cancer Res. 2004 Apr 15;10(8):2670-4. doi: 10.1158/1078-0432.ccr-03-0114. Clin Cancer Res. 2004. PMID: 15102669

6

Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential.

Zafrakas M, Tarlatzis BC, Streichert T, Pournaropoulos F, Wölfle U, Smeets SJ, Wittek B, Grimbizis G, Brakenhoff RH, Pantel K, Bontis J, Günes C. Zafrakas M, et al. Among authors: brakenhoff rh. Int J Mol Med. 2008 Mar;21(3):335-44. Int J Mol Med. 2008. PMID: 18288381

7

Minimal residual disease in head and neck cancer.

Gath HJ, Brakenhoff RH. Gath HJ, et al. Among authors: brakenhoff rh. Cancer Metastasis Rev. 1999;18(1):109-26. doi: 10.1023/a:1006268621730. Cancer Metastasis Rev. 1999. PMID: 10505550 Review.

8

Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.

de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH. de Nooij-van Dalen AG, et al. Among authors: brakenhoff rh. Int J Cancer. 2003 Mar 1;103(6):768-74. doi: 10.1002/ijc.10903. Int J Cancer. 2003. PMID: 12516096 Free article.

9

The molecular biology of head and neck cancer.

Leemans CR, Braakhuis BJ, Brakenhoff RH. Leemans CR, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2011 Jan;11(1):9-22. doi: 10.1038/nrc2982. Epub 2010 Dec 16. Nat Rev Cancer. 2011. PMID: 21160525 Review.

10

Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure.

Partridge M, Brakenhoff R, Phillips E, Ali K, Francis R, Hooper R, Lavery K, Brown A, Langdon J. Partridge M, et al. Clin Cancer Res. 2003 Nov 1;9(14):5287-94. Clin Cancer Res. 2003. PMID: 14614011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page